Visfatin serum levels in chronic hepatitis C patients
- 12 March 2010
- journal article
- Published by Wiley in Journal of Viral Hepatitis
- Vol. 17 (4) , 254-260
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Visfatin, low‐grade inflammation and body mass index (BMI)Clinical Endocrinology, 2008
- The novel adipocytokine visfatin exerts direct cardioprotective effectsJournal of Cellular and Molecular Medicine, 2008
- The role of adipokines in liver fibrosisPathophysiology, 2008
- Obesity and steatosis influence serum and hepatic inflammatory markers in chronic hepatitis C†Hepatology, 2008
- Visfatin induces human endothelial VEGF and MMP-2/9 production via MAPK and PI3K/Akt signalling pathways: novel insights into visfatin-induced angiogenesisCardiovascular Research, 2007
- Changes in plasma levels of fat-derived hormones adiponectin, leptin, resistin and visfatin in patients with rheumatoid arthritisAnnals of the Rheumatic Diseases, 2006
- Plasma resistin concentration, and steatosis and insulin sensitivity in hepatitis C virus‐infected patientsJournal of Gastroenterology and Hepatology, 2006
- Visfatin: A Protein Secreted by Visceral Fat That Mimics the Effects of InsulinScience, 2005
- Cold ischemia decreases liver regeneration after partial liver transplantation in the rat: A TNF-α/IL-6-dependent mechanismHepatology, 2002
- The nomenclature of chronic hepatitis: time for a changeJournal of Hepatology, 1995